A Drug Interaction Study of ACH-0145228

Study Identifier:
ACH228-003
ClinicalTrials.gov Identifier:
NCT04709081
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Other
Study Drug
  • Drug: ACH-0145228
  • Drug: Midazolam
  • Drug: Digoxin
  • Drug: Itraconazole
Date
Dec 2019 - Apr 2020
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 55 Years
Requirements Information
Sex
Female & Male
Age
18 - 55 Years

Study Details

Medical Condition
  • Other
Study Drug
  • Drug: ACH-0145228
  • Drug: Midazolam
  • Drug: Digoxin
  • Drug: Itraconazole
Date
Dec 2019 - Apr 2020
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 55 Years years
Requirements Information

Protocol Summary

This was a 2-part study (Part 1 and Part 2), with each part being an open-label, fixed sequence, 2-period study in healthy adult participants.

Trial Locations

Location
Status
Location
Clinical Study Site
Tempe, Arizona, United States, 85283
Status
N/A